The Current Ratio as of November 2024 (TTM) for H-CYTE, Inc. (HCYT) is 0.08

According to H-CYTE, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.08. This represents a change of 112.27% compared to the average of 0.04 of the last 4 quarters.

H-CYTE, Inc. (HCYT) Historical Current Ratio (quarterly & annually)

How has HCYT Current Ratio performed in the past?

The mean historical Current Ratio of H-CYTE, Inc. over the last ten years is 6.58. The current 0.08 Current Ratio has changed 17.99% with respect to the historical average. Over the past ten years (40 quarters), HCYT's Current Ratio was at its highest in in the December 2014 quarter at 19.00. The Current Ratio was at its lowest in in the December 2022 quarter at 0.01.

H-CYTE, Inc. (HCYT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of H-CYTE, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

H-CYTE, Inc. (HCYT) Average Current Ratio

How has HCYT Current Ratio performed in the past?

The current Current Ratio of H-CYTE, Inc. (HCYT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

H-CYTE, Inc. (HCYT) Current Ratio vs. Peers

How is HCYT’s Current Ratio compared to its peers?

H-CYTE, Inc.’s Current Ratio is less than Algernon Pharmaceuticals Inc. (0.36), less than Adynxx, Inc. (0), greater than Ascletis Pharma Inc. (0), less than BioCardia, Inc. (24.38), less than Genelux Corporation (0.39), less than Comera Life Sciences Holdings, Inc. (6.01), less than Dyadic International, Inc. (0.90), less than Cingulate Inc. (5.39), less than Monopar Therapeutics Inc. (1.20), less than Wesana Health Holdings Inc. (6.59), less than BioVaxys Technology Corp. (0.13), less than GH Research PLC (0.39), less than AXIM Biotechnologies, Inc. (19.60), greater than Aura Biosciences, Inc. (0.00), less than Axcella Health Inc. (18.54), less than Bavarian Nordic A/S (0.80), less than Antibe Therapeutics Inc. (1.48), less than null (10.06),

Build a custom stock screener for H-CYTE, Inc. (HCYT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like H-CYTE, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

H-CYTE, Inc. (HCYT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like H-CYTE, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.